Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Income from Continuing Operations (2021 - 2025)

Historic Income from Continuing Operations for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$2.4 million.

  • HeartSciences' Income from Continuing Operations fell 1190.44% to -$2.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$9.1 million, marking a year-over-year decrease of 1701.1%. This contributed to the annual value of -$8.9 million for FY2025, which is 3293.13% down from last year.
  • Per HeartSciences' latest filing, its Income from Continuing Operations stood at -$2.4 million for Q4 2025, which was down 1190.44% from -$2.1 million recorded in Q3 2025.
  • HeartSciences' 5-year Income from Continuing Operations high stood at -$752051.0 for Q3 2021, and its period low was -$2.6 million during Q1 2025.
  • Its 5-year average for Income from Continuing Operations is -$1.7 million, with a median of -$1.8 million in 2022.
  • As far as peak fluctuations go, HeartSciences' Income from Continuing Operations plummeted by 10925.5% in 2022, and later surged by 2054.79% in 2023.
  • Quarter analysis of 5 years shows HeartSciences' Income from Continuing Operations stood at -$1.0 million in 2021, then tumbled by 74.7% to -$1.8 million in 2022, then grew by 3.28% to -$1.7 million in 2023, then fell by 20.26% to -$2.1 million in 2024, then decreased by 11.9% to -$2.4 million in 2025.
  • Its Income from Continuing Operations was -$2.4 million in Q4 2025, compared to -$2.1 million in Q3 2025 and -$2.1 million in Q2 2025.